title: Response to: Comment on 'Effect of a low dose of gonadotropin releasing hormone antagonist on in vitro fertilization outcomes' by Kerimoğlu et al.: Cetrorelix in COH cycles: time to re-evaluate the daily administered dose?
authors.affiliation: Obstetrics and Gynecology Department, Selcuk University Medicine Faculty, Konya, Turkey, ozlemsecilmis@hotmail.com.
authors.forename: Ozlem Secilmis
authors.initials: OS
authors.lastname: Kerimoğlu
authors.forename: Cihangir Mutlu
authors.initials: CM
authors.lastname: Ercan
mesh_terms: D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors*; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism*; D008297:Male; D010062:Ovulation Induction; D011247:Pregnancy
chemical_list: D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone